Core Insights - The company held a mid-year management meeting on July 19 to summarize achievements and shortcomings, analyze industry trends, and set strategic plans for the second half of the year [1][3] - The chairman and CEO, Gao Chunpo, emphasized the current pharmaceutical industry is undergoing a deep adjustment period with intensified competition and ongoing policy impacts, urging the company to find its market position amid these challenges [3][5] Group 1 - Each department head presented their work, achievements, innovations, challenges, and plans for the second half of 2025, showcasing the diligent efforts of the company [3] - Gao Chunpo highlighted the need for a long-term perspective to navigate through cyclical fluctuations and to create new opportunities amid changes [3][5] Group 2 - For the second half of the year, the chairman called for collaborative efforts across systems, focusing on market penetration, operational efficiency, and enhancing product competitiveness through technological improvements [5] - The meeting served as both a review of past work and a motivational rallying point for management to align on goals and drive high-quality development in the face of industry transformation [5]
科源制药召开述职大会：2025年下半年各系统协同发力，在行业变革中实现高质量发展